Timeline
CEPI
Oslo-based pandemic vaccine finance partnership; backed Moderna's Phase 3 H5N1 mRNA trial launched April 2026.
2 of 2 entries (2 events, 0 interactions)
Filters
#122 Apr
Announced first Phase 3 trial of mRNA H5N1 vaccine candidate and expanded partnerships with Pasteur Network and PAHO
Pandemics and Biosecurity: Moderna begins Phase 3 H5N1 mRNA trial#131 Mar